NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today announced scientific presentations at three upcoming conferences.
The IPBN’s second annual Tourism Conference is set to occur in the Algarve on Wednesday, May 24 at the Quinta do Lago Clubhouse from 0900 to 1pm and promises.